89 related articles for article (PubMed ID: 4574182)
1. [Pathophysiology and medical treatment of Raynaud's phenomena].
Adar R
Harefuah; 1973 Feb; 84(4):227-8. PubMed ID: 4574182
[No Abstract] [Full Text] [Related]
2. Reserpine and Raynaud's phenomenon.
Gifford RW
N Engl J Med; 1971 Jul; 285(5):290-1. PubMed ID: 5090401
[No Abstract] [Full Text] [Related]
3. [Spasm and Raynaud's phenomenon].
Fiessinger JN
Ann Cardiol Angeiol (Paris); 1981; 30(2):91-3. PubMed ID: 7259052
[No Abstract] [Full Text] [Related]
4. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease].
Acevedo A; Palacios JM; López R; Palma F
Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168
[No Abstract] [Full Text] [Related]
5. Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.
Nilsen KH; Jayson MI
Br Med J; 1980 Jun; 280(6229):1408-11. PubMed ID: 7427134
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of Raynaud's disease.
Halperin JL; Coffman JD
Arch Intern Med; 1979 Jan; 139(1):89-92. PubMed ID: 760690
[No Abstract] [Full Text] [Related]
7. Effect of reserpine in Raynaud's phenomenon.
Kontos HA; Wasserman AJ
Circulation; 1969 Feb; 39(2):259-66. PubMed ID: 5763842
[No Abstract] [Full Text] [Related]
8. Medical treatment in Raynaud's disease.
Hansteen V
Acta Chir Scand Suppl; 1976; 465():87-91. PubMed ID: 793268
[No Abstract] [Full Text] [Related]
9. Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
Surwit RS; Gilgor RS; Duvic M; Allen LM; Neal JA
Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic management of Raynaud's phenomenon.
Day TW; Mendoza F
South Med J; 1984 Sep; 77(9):1160-4. PubMed ID: 6385288
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Raynaud's phenomenon by methyldopa.
Varadi DP; Lawrence AM
Arch Intern Med; 1969 Jul; 124(1):13-8. PubMed ID: 5791479
[No Abstract] [Full Text] [Related]
12. [Pharmacotherapy of Raynaud's phenomenon].
Allegra C; Criscuolo A; Pollari G; Bonifacio M; Nunes P
Minerva Cardioangiol; 1983 Sep; 31(9):465-8. PubMed ID: 6669262
[No Abstract] [Full Text] [Related]
13. [Hemorheological, hemocoagulation and photoplethysmographic changes induced by the administration of pentoxifylline in patients with Raynaud's disease].
Macchione C; Molaschi M; Neirotti M; Garrone MT; Longo F; Pernigotti L
Minerva Med; 1985 Jul; 76(30-31):1401-5. PubMed ID: 4022431
[TBL] [Abstract][Full Text] [Related]
14. [Intra-arterial reserpine in Raynaud's disease and syndrome].
Arcas Meca R; Ono Okabe S; Barroso-Moguel R; Quijano Pitman F
Arch Inst Cardiol Mex; 1972; 42(2):260-8. PubMed ID: 5028993
[No Abstract] [Full Text] [Related]
15. Cold extremities: investigation and management of Raynaud's phenomenon.
Farrington NK; Sutej PG
J South Orthop Assoc; 1996; 5(1):37-45. PubMed ID: 8673588
[TBL] [Abstract][Full Text] [Related]
16. Raynaud's disease presenting in a 5-month-old-male infant.
Sayre JW
Pediatrics; 1973 Sep; 52(3):412-5. PubMed ID: 4730398
[No Abstract] [Full Text] [Related]
17. Historical review of Raynaud's phenomenon nomenclature and pathophysiology.
Lemmens HA
Vasa Suppl; 1987; 18():10-4. PubMed ID: 3299812
[No Abstract] [Full Text] [Related]
18. Reserpine and Raynaud's phenomenon.
Uman SJ
Ann Intern Med; 1972 Dec; 77(6):1005. PubMed ID: 4644162
[No Abstract] [Full Text] [Related]
19. Pathogenesis of Raynaud's phenomenon.
Herrick AL
Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
[TBL] [Abstract][Full Text] [Related]
20. Raynaud's phenomenon: peripheral catecholamine concentration and effect of sympathectomy.
Nielsen SL; Christensen NJ; Olsen N; Lassen NA
Acta Chir Scand Suppl; 1980; 502():57-62. PubMed ID: 6941602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
